Physician profile
Alfredo Ramirez
NPI 1003829417
$3,331.57
in general payments reported to CMS, 2019-2025
14 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $279 · 2021: $97.53 · 2022: $278 · 2023: $14.98 · 2024: $1,104 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,205 · Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,204.52 |
| Food and Beverage | $1,036.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,464.48 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $499.54 | 2019-2022 | |
| Atricure, INC. | $435.06 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Aop Health US, LLC | $310.02 | 2025 | Rapiblyk |
| Kls-Martin L.P. | $185.41 | 2022 | |
| Ethicon US, LLC | $94.93 | 2024-2025 | Vistaseal, Surgicel Nu-Knit, Dermabond Prineo |
| W. L. Gore & Associates, INC. | $82.90 | 2021 | |
| Cgg Medical INC | $82.31 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $55.62 | 2022 | |
| Penumbra, INC. | $52.27 | 2024 | Indigo System |
| Lsi Solutions INC | $20.21 | 2024 | Cor-Knot |
| Davol INC. | $20.13 | 2020 | |
| Pfizer INC. | $14.98 | 2023 | |
| Abbott Laboratories | $13.71 | 2025 | Navitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfredo Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.